Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.

Keywords

Sick child, Medicine, Pediatrics

References

• Cyclooxygenase-2 and chemoprevention of breast cancer.Paul Kimmage — 2003
• Aromatase and breast cancer.Shiuan Chen — 1998
• Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.T Vink-van Wijngaarden, H. A. P. Pols, C J Buurman — 1994
• Vitamin D status and cancer incidence and mortality.Edward L. Giovannucci — 2008
• Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen.Junko Abe-Hashimoto, Tomoko Kikuchi, Tsunekazu Matsumoto — 1993
• Vitamin D-3 receptor as a target for breast cancer prevention.JoEllen Welsh, Jennifer A. Wietzke, Glendon M. Zinser — 2003
• Vitamin D and colon carcinogenesis.Diane M. Harris, Vay Liang W. Go — 2004
• Calcitriol in cancer treatment: from the lab to the clinic.Tomasz M. Beer, Anne Myrthue — 2004
• Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.Aruna V. Krishnan, Jacqueline Moreno, Larisa Nonn — 2007
• A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.T. Gulliford, J English, K W Colston — 1998
• Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis.Grisha Pirianov, K W Colston — 2001
• Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: Reanalysis of Women's Health Initiative randomized trialEric L. Ding, Saurabh Mehta, Wafaie Fawzi — 2007
• Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors.Betty A. Mincey, Mei Sheng Duh, Simu K. Thomas — 2006
• Aromatase expression in the human breastAngela Brodie, Brian J. Long, Qing Lü — 2004
• Vitamin D3 receptor (VDR) expression in HC‐11 mammary cells: regulation by growth‐modulatory agents, differentiation, and Ha‐ras transformationM T F Escaleira, Maria Mitzi Brentani — 1999
• Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cellsMaura Simboli-Campbell, Carmen J. Narvaez, Kathryn VanWeelden — 2004
• 1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes.Susan V. Hughes, Elaine Robinson, Rosemary Bland — 1997
• Aromatase and COX-2 expression in human breast cancers.A. Brodie, Qing Lü, Brian J. Long — 2001
• Aromatase Inhibition: Translation into a Successful Therapeutic ApproachJürgen Geisler, Per Eystein Lønning — 2005
• Targets of Vitamin D Receptor Signaling in the Mammary GlandJoEllen Welsh — 2007

Cited by

• Bone mineral density and non-osteoporotic disease.M. Kiramura — 2010
• Re: "overview of the cohort consortium vitamin D pooling project of rarer cancers".Andreas Messmann, Thorsten Kornblum — 2010
• 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism.Jacobo Hernández Barranco, Denis Paredes González — 2011
• Vitamin D metabolism, sex hormones, and male reproductive function.Stéphanie Andre — 2012
• Lack of association between vitamin D receptor gene BsmI polymorphism and breast cancer risk: an updated meta-analysis involving 23,020 subjectsMónica Fuertes — 2013
• Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients.進二 山田, 和夫 松尾, 輝俊 福田 — 2014
• Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosisEsther Caspary — 2014
• 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages.Barbara Villaggio, Stefano Soldano, Maurizio Cutolo — 2012
• Association of serum 25-OHD concentrations with maternal sex-steroids and IGF-1 hormones during pregnancyAdetunji T. Toriola, Heljä‐Marja Surcel, Anika Hüsing — 2011
• Vitamin D Induces Cyclooxygenase 2 Dependent Prostaglandin E2 Synthesis in HaCaT KeratinocytesAmiram Ravid, Ohad Shenker, Efrat Buchner‐Maman — 2016
• The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancerNigel T. Brockton, Stephanie Gill, Stephanie L. Laborge — 2015
• Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathwayRuili Huang, Srilatha Sakamuru, Matt Martin — 2014
• EFFECT OF HORMONE THERAPY AND CALCITRIOL ON SERUM LIPID PROFILE IN POSTMENOPAUSAL ELDERLY WOMEN: ASSOCIATION WITH ESTROGEN RECEPTOR ALPHA GENOTYPESAdarsh Sai, John C. Gallagher, Xiang Fang — 2011
• Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast CancerHee Jeong Kim, Yu Mi Lee, Beon Seok Ko — 2010
• [Vitamin D and cancers].Marc Espié, Johanna Wassermann, Elisabeth de Kermadec — 2013
• The Potential Therapeutic Benefits of Vitamin D in the Treatment of Estrogen Receptor Positive Breast CancerAruna V. Krishnan, Srilatha Swami, David Feldman — 2012
• Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma.Sang Hyuk Seo, Mi Seon Kang, Kwang Hee Kim — 2015
• 1,25-dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytesDan Gao, Paul Trayhurn, C Bing — 2012
• The Role of the rs1544410 Polymorphism of Vitamin D Receptor Gene in Breast Cancer SusceptibilityXiaorui Li, Xiaoqing Huo, Weiwei Li — 2014
• Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivoSrilatha Swami, Aruna V. Krishnan, Jennifer Y. Wang — 2011

Related papers

No related papers recorded.